Home
/ Paion
/ Competitors

Paion Competitors and Similar CompaniesClear all

Array BioPharma's competitors and similar companies include ObsEva, Affimed N.V. and Avid Bioservices.

	Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.	ObsEva ObsEva is a speciality biopharmaceutical company developing drugs for womens reproductive medicine.	Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.	Avid Bioservices Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.
Founding Date	Founding Date 1998	Founding Date 2012	Founding Date 2000	Founding Date 1981
Type	Type Subsidiary	Type Private	Type Public	Type Public
Tags	Tags Healthcare clinics pharma	Tags Healthcare clinics pharma	Tags Healthcare clinics pharma	Tags Healthcare clinics pharma
Locations	Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US	Locations Plan-les-Ouates, CH HQ Boston, US Sacramento, US	Locations Heidelberg, DE HQ	Locations Tustin, US HQ
Employees	Employees 110	Employees 811% decrease	Employees 76	Employees 21114% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 52.5 m	Valuation ($) 649.4 m
Financial
Revenue (est.)	Revenue (est.) $173.8m (FY, 2018)	Revenue (est.) N/A	Revenue (est.) €8.3m (FY, 2023)	Revenue (est.) $139.9m (FY, 2024)
Cost of goods	Cost of goods $59.4m (FY, 2018)	Cost of goods N/A	Cost of goods N/A	Cost of goods $132.6m (FY, 2024)
Gross profit	Gross profit $114.4m (FY, 2018)	Gross profit N/A	Gross profit €13m (FY, 2023)	Gross profit $7.3m (FY, 2024)
Net income	Net income ($147.7m) (FY, 2018)	Net income N/A	Net income (€105.9m) (FY, 2023)	Net income ($140.8m) (FY, 2024)